Tango Therapeutics, Inc. Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

TNGX

Rang în acțiuni #4540
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Preț acțiune
$27.18
Ultima sincronizare: 2026-07-31
Capitalizare de piață
$3.38B
Schimbare (1 zi)
-1.41%
Schimbare (1 an)
197.05%
Țară
US
Tranzacționează Tango Therapeutics, Inc. (TNGX)

Categorie

Healthcare
Istoricul randamentului dividendelor pentru Tango Therapeutics, Inc. (TNGX)
Randamentul dividendelor (TTM) pentru Tango Therapeutics, Inc. (simbol acțiune: TNGX) la data de 2023-12-31 este: 0.00%
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru Tango Therapeutics, Inc. (TNGX) între 2019 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL